Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,298
archived clinical trials in
Insomnia Sleep Studies

Study of the Effect of Individualizing Daytrana Wear-times on Sleep in Children 6-12 Years Old With Attention Deficit Hyperactivity Disorder (ADHD)
Open Label Study of the Effect of Individualizing Daytrana Wear-times on Sleep in Children 6-12 Years Old With ADHD
Status: Archived
Pediatric Neurology of the Ozarks
mi
from
Springfield, MO
Study of the Effect of Individualizing Daytrana Wear-times on Sleep in Children 6-12 Years Old With Attention Deficit Hyperactivity Disorder (ADHD)
Open Label Study of the Effect of Individualizing Daytrana Wear-times on Sleep in Children 6-12 Years Old With ADHD
Status: Archived
Updated: 1/1/1970
Pediatric Neurology of the Ozarks
mi
from
Springfield, MO
Safety and Efficacy of Chronic Hypnotic Use
Abuse Liability Associated With Chronic Hypnotic Use
Status: Archived
Henry Ford Hospital
mi
from
Detroit, MI
Safety and Efficacy of Chronic Hypnotic Use
Abuse Liability Associated With Chronic Hypnotic Use
Status: Archived
Updated: 1/1/1970
Henry Ford Hospital
mi
from
Detroit, MI
Prevalence of Sleep Disordered Breathing
Prevalence of Sleep Disordered Breathing
Status: Archived
Ohio State University
mi
from
Columbus, OH
Prevalence of Sleep Disordered Breathing
Prevalence of Sleep Disordered Breathing
Status: Archived
Updated: 1/1/1970
Ohio State University
mi
from
Columbus, OH
Snoring in Pregnancy and Adverse Maternal and Fetal Outcomes
The Impact of Sleep-Disordered Breathing on Adverse Pregnancy Outcomes
Status: Archived
University of Michigan Health Systems
mi
from
Ann Arbor, MI
Snoring in Pregnancy and Adverse Maternal and Fetal Outcomes
The Impact of Sleep-Disordered Breathing on Adverse Pregnancy Outcomes
Status: Archived
Updated: 1/1/1970
University of Michigan Health Systems
mi
from
Ann Arbor, MI
Positional Therapy After Stroke
Positional Therapy After Stroke
Status: Archived
University of Michigan Health Systems
mi
from
Ann Arbor, MI
Positional Therapy After Stroke
Positional Therapy After Stroke
Status: Archived
Updated: 1/1/1970
University of Michigan Health Systems
mi
from
Ann Arbor, MI
Face of Sleepiness
The Face of Sleepiness
Status: Archived
University of Michigan Health Systems
mi
from
Ann Arbor, MI
Face of Sleepiness
The Face of Sleepiness
Status: Archived
Updated: 1/1/1970
University of Michigan Health Systems
mi
from
Ann Arbor, MI
Intensive Care Unit (ICU) Sleep Quality and Neurocognitive Performance
Post-ICU Neurocognitive Performance and Sleep Quality Ratings Following Exposure to a Medical ICU Sleep Quality Improvement Project
Status: Archived
Johns Hopkins Hosp
mi
from
Baltimore, MD
Intensive Care Unit (ICU) Sleep Quality and Neurocognitive Performance
Post-ICU Neurocognitive Performance and Sleep Quality Ratings Following Exposure to a Medical ICU Sleep Quality Improvement Project
Status: Archived
Updated: 1/1/1970
Johns Hopkins Hosp
mi
from
Baltimore, MD
Sleep Apnea Treatment With Expiratory Resistance(Proventâ„¢)
Sleep Apnea Treatment With Expiratory Resistance(Proventâ„¢)
Status: Archived
Johns Hopkins Asthma and Allergy Center
mi
from
Baltimore, MD
Sleep Apnea Treatment With Expiratory Resistance(Proventâ„¢)
Sleep Apnea Treatment With Expiratory Resistance(Proventâ„¢)
Status: Archived
Updated: 1/1/1970
Johns Hopkins Asthma and Allergy Center
mi
from
Baltimore, MD
Heart Biomarker Evaluation in Apnea Treatment
Phase II Trial of Sleep Apnea Treatment to Reduce Cardiovascular Morbidity
Status: Archived
Johns Hopkins University
mi
from
Baltimore, MD
Heart Biomarker Evaluation in Apnea Treatment
Phase II Trial of Sleep Apnea Treatment to Reduce Cardiovascular Morbidity
Status: Archived
Updated: 1/1/1970
Johns Hopkins University
mi
from
Baltimore, MD
Heart Biomarker Evaluation in Apnea Treatment
Phase II Trial of Sleep Apnea Treatment to Reduce Cardiovascular Morbidity
Status: Archived
Partners HealthCare
mi
from
Boston, MA
Heart Biomarker Evaluation in Apnea Treatment
Phase II Trial of Sleep Apnea Treatment to Reduce Cardiovascular Morbidity
Status: Archived
Updated: 1/1/1970
Partners HealthCare
mi
from
Boston, MA
Heart Biomarker Evaluation in Apnea Treatment
Phase II Trial of Sleep Apnea Treatment to Reduce Cardiovascular Morbidity
Status: Archived
VA Boston Health Care System
mi
from
Boston, MA
Heart Biomarker Evaluation in Apnea Treatment
Phase II Trial of Sleep Apnea Treatment to Reduce Cardiovascular Morbidity
Status: Archived
Updated: 1/1/1970
VA Boston Health Care System
mi
from
Boston, MA
Heart Biomarker Evaluation in Apnea Treatment
Phase II Trial of Sleep Apnea Treatment to Reduce Cardiovascular Morbidity
Status: Archived
Case Western Reserve Univ
mi
from
Cleveland, OH
Heart Biomarker Evaluation in Apnea Treatment
Phase II Trial of Sleep Apnea Treatment to Reduce Cardiovascular Morbidity
Status: Archived
Updated: 1/1/1970
Case Western Reserve Univ
mi
from
Cleveland, OH
Pharmacodynamics and Efficacy of MK7288 (7288-010)
An Active-Comparator Controlled Single Dose Study to Evaluate the Pharmacodynamics/Efficacy of MK7288
Status: Archived
Abington Memorial Hospital
mi
from
Abington, PA
Pharmacodynamics and Efficacy of MK7288 (7288-010)
An Active-Comparator Controlled Single Dose Study to Evaluate the Pharmacodynamics/Efficacy of MK7288
Status: Archived
Updated: 1/1/1970
Abington Memorial Hospital
mi
from
Abington, PA
Pharmacodynamics and Efficacy of MK7288 (7288-010)
An Active-Comparator Controlled Single Dose Study to Evaluate the Pharmacodynamics/Efficacy of MK7288
Status: Archived
Clinical Research Facility
mi
from
Atlanta, GA
Pharmacodynamics and Efficacy of MK7288 (7288-010)
An Active-Comparator Controlled Single Dose Study to Evaluate the Pharmacodynamics/Efficacy of MK7288
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Atlanta, GA
Pharmacodynamics and Efficacy of MK7288 (7288-010)
An Active-Comparator Controlled Single Dose Study to Evaluate the Pharmacodynamics/Efficacy of MK7288
Status: Archived
Clinical Research Facility
mi
from
Falls Church, VA
Pharmacodynamics and Efficacy of MK7288 (7288-010)
An Active-Comparator Controlled Single Dose Study to Evaluate the Pharmacodynamics/Efficacy of MK7288
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Falls Church, VA
Safety and Efficacy Study in Primary Insomnia Patients- Study A (4305-028)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of MK4305 in Patients With Primary Insomnia- Study A
Status: Archived
Baystate Med Ctr of Springfield
mi
from
Springfield, MA
Safety and Efficacy Study in Primary Insomnia Patients- Study A (4305-028)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of MK4305 in Patients With Primary Insomnia- Study A
Status: Archived
Updated: 1/1/1970
Baystate Med Ctr of Springfield
mi
from
Springfield, MA
Safety and Efficacy Study in Primary Insomnia Patients- Study A (4305-028)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of MK4305 in Patients With Primary Insomnia- Study A
Status: Archived
Center for Fertility and Women's Health
mi
from
New Britain, CT
Safety and Efficacy Study in Primary Insomnia Patients- Study A (4305-028)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of MK4305 in Patients With Primary Insomnia- Study A
Status: Archived
Updated: 1/1/1970
Center for Fertility and Women's Health
mi
from
New Britain, CT
Safety and Efficacy Study in Primary Insomnia Patients- Study A (4305-028)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of MK4305 in Patients With Primary Insomnia- Study A
Status: Archived
Abington Memorial Hospital
mi
from
Abington, PA
Safety and Efficacy Study in Primary Insomnia Patients- Study A (4305-028)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of MK4305 in Patients With Primary Insomnia- Study A
Status: Archived
Updated: 1/1/1970
Abington Memorial Hospital
mi
from
Abington, PA
Safety and Efficacy Study in Primary Insomnia Patients- Study A (4305-028)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of MK4305 in Patients With Primary Insomnia- Study A
Status: Archived
Clinical Research Facility
mi
from
Atlanta, GA
Safety and Efficacy Study in Primary Insomnia Patients- Study A (4305-028)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of MK4305 in Patients With Primary Insomnia- Study A
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Atlanta, GA
Safety and Efficacy Study in Primary Insomnia Patients- Study A (4305-028)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of MK4305 in Patients With Primary Insomnia- Study A
Status: Archived
Clinical Research Facility
mi
from
Kansas City, KA
Safety and Efficacy Study in Primary Insomnia Patients- Study A (4305-028)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of MK4305 in Patients With Primary Insomnia- Study A
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Kansas City, KA
Safety and Efficacy Study in Primary Insomnia Patients- Study A (4305-028)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of MK4305 in Patients With Primary Insomnia- Study A
Status: Archived
Clinical Research Facility
mi
from
Lexington, KY
Safety and Efficacy Study in Primary Insomnia Patients- Study A (4305-028)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of MK4305 in Patients With Primary Insomnia- Study A
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Lexington, KY
Safety and Efficacy Study in Primary Insomnia Patients- Study A (4305-028)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of MK4305 in Patients With Primary Insomnia- Study A
Status: Archived
Clinical Research Facility
mi
from
Baltimore, MD
Safety and Efficacy Study in Primary Insomnia Patients- Study A (4305-028)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of MK4305 in Patients With Primary Insomnia- Study A
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Baltimore, MD
Safety and Efficacy Study in Primary Insomnia Patients- Study A (4305-028)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of MK4305 in Patients With Primary Insomnia- Study A
Status: Archived
Clinical Research Facility
mi
from
Springfield, MA
Safety and Efficacy Study in Primary Insomnia Patients- Study A (4305-028)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of MK4305 in Patients With Primary Insomnia- Study A
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Springfield, MA
Safety and Efficacy Study in Primary Insomnia Patients- Study A (4305-028)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of MK4305 in Patients With Primary Insomnia- Study A
Status: Archived
Clinical Research Facility
mi
from
New York, NY
Safety and Efficacy Study in Primary Insomnia Patients- Study A (4305-028)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of MK4305 in Patients With Primary Insomnia- Study A
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
New York, NY
Safety and Efficacy Study in Primary Insomnia Patients- Study A (4305-028)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of MK4305 in Patients With Primary Insomnia- Study A
Status: Archived
Clinical Research Facility
mi
from
Asheville, NC
Safety and Efficacy Study in Primary Insomnia Patients- Study A (4305-028)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of MK4305 in Patients With Primary Insomnia- Study A
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Asheville, NC
Safety and Efficacy Study in Primary Insomnia Patients- Study A (4305-028)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of MK4305 in Patients With Primary Insomnia- Study A
Status: Archived
Clinical Research Facility
mi
from
Oklahoma City, OK
Safety and Efficacy Study in Primary Insomnia Patients- Study A (4305-028)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of MK4305 in Patients With Primary Insomnia- Study A
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Oklahoma City, OK
Safety and Efficacy Study in Primary Insomnia Patients- Study A (4305-028)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of MK4305 in Patients With Primary Insomnia- Study A
Status: Archived
Clinical Research Facility
mi
from
Pawtucket, RI
Safety and Efficacy Study in Primary Insomnia Patients- Study A (4305-028)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of MK4305 in Patients With Primary Insomnia- Study A
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Pawtucket, RI
Safety and Efficacy Study in Primary Insomnia Patients- Study A (4305-028)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of MK4305 in Patients With Primary Insomnia- Study A
Status: Archived
Clinical Research Facility
mi
from
Chattanooga, TN
Safety and Efficacy Study in Primary Insomnia Patients- Study A (4305-028)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of MK4305 in Patients With Primary Insomnia- Study A
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Chattanooga, TN
Safety and Efficacy Study in Primary Insomnia Patients- Study A (4305-028)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of MK4305 in Patients With Primary Insomnia- Study A
Status: Archived
Clinical Research Facility
mi
from
Dallas, TX
Safety and Efficacy Study in Primary Insomnia Patients- Study A (4305-028)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of MK4305 in Patients With Primary Insomnia- Study A
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Dallas, TX
Safety and Efficacy Study in Primary Insomnia Patients- Study A (4305-028)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of MK4305 in Patients With Primary Insomnia- Study A
Status: Archived
Clinical Research Facility
mi
from
Salt Lake City, UT
Safety and Efficacy Study in Primary Insomnia Patients- Study A (4305-028)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of MK4305 in Patients With Primary Insomnia- Study A
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Salt Lake City, UT
Safety and Efficacy Study in Primary Insomnia Patients- Study A (4305-028)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of MK4305 in Patients With Primary Insomnia- Study A
Status: Archived
Clinical Research Facility
mi
from
Falls Church, VA
Safety and Efficacy Study in Primary Insomnia Patients- Study A (4305-028)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of MK4305 in Patients With Primary Insomnia- Study A
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Falls Church, VA
Safety and Efficacy Study in Primary Insomnia Patients-Study B (4305-029)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of MK4305 in Patients With Primary Insomnia- Study B
Status: Archived
Baystate Med Ctr of Springfield
mi
from
Springfield, MA
Safety and Efficacy Study in Primary Insomnia Patients-Study B (4305-029)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of MK4305 in Patients With Primary Insomnia- Study B
Status: Archived
Updated: 1/1/1970
Baystate Med Ctr of Springfield
mi
from
Springfield, MA
Safety and Efficacy Study in Primary Insomnia Patients-Study B (4305-029)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of MK4305 in Patients With Primary Insomnia- Study B
Status: Archived
Memorial Hospital of Rhode Island
mi
from
Pawtucket, RI
Safety and Efficacy Study in Primary Insomnia Patients-Study B (4305-029)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of MK4305 in Patients With Primary Insomnia- Study B
Status: Archived
Updated: 1/1/1970
Memorial Hospital of Rhode Island
mi
from
Pawtucket, RI
Safety and Efficacy Study in Primary Insomnia Patients-Study B (4305-029)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of MK4305 in Patients With Primary Insomnia- Study B
Status: Archived
Center for Fertility and Women's Health
mi
from
New Britain, CT
Safety and Efficacy Study in Primary Insomnia Patients-Study B (4305-029)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of MK4305 in Patients With Primary Insomnia- Study B
Status: Archived
Updated: 1/1/1970
Center for Fertility and Women's Health
mi
from
New Britain, CT
Safety and Efficacy Study in Primary Insomnia Patients-Study B (4305-029)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of MK4305 in Patients With Primary Insomnia- Study B
Status: Archived
Abington Memorial Hospital
mi
from
Abington, PA
Safety and Efficacy Study in Primary Insomnia Patients-Study B (4305-029)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of MK4305 in Patients With Primary Insomnia- Study B
Status: Archived
Updated: 1/1/1970
Abington Memorial Hospital
mi
from
Abington, PA
Safety and Efficacy Study in Primary Insomnia Patients-Study B (4305-029)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of MK4305 in Patients With Primary Insomnia- Study B
Status: Archived
Clinical Research Facility
mi
from
Atlanta, GA
Safety and Efficacy Study in Primary Insomnia Patients-Study B (4305-029)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of MK4305 in Patients With Primary Insomnia- Study B
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Atlanta, GA
Safety and Efficacy Study in Primary Insomnia Patients-Study B (4305-029)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of MK4305 in Patients With Primary Insomnia- Study B
Status: Archived
Clinical Research Facility
mi
from
Oak Lawn, IL
Safety and Efficacy Study in Primary Insomnia Patients-Study B (4305-029)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of MK4305 in Patients With Primary Insomnia- Study B
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Oak Lawn, IL
Safety and Efficacy Study in Primary Insomnia Patients-Study B (4305-029)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of MK4305 in Patients With Primary Insomnia- Study B
Status: Archived
Clinical Research Facility
mi
from
Kansas City, KA
Safety and Efficacy Study in Primary Insomnia Patients-Study B (4305-029)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of MK4305 in Patients With Primary Insomnia- Study B
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Kansas City, KA
Safety and Efficacy Study in Primary Insomnia Patients-Study B (4305-029)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of MK4305 in Patients With Primary Insomnia- Study B
Status: Archived
Clinical Research Facility
mi
from
Springfield, MA
Safety and Efficacy Study in Primary Insomnia Patients-Study B (4305-029)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of MK4305 in Patients With Primary Insomnia- Study B
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Springfield, MA
Safety and Efficacy Study in Primary Insomnia Patients-Study B (4305-029)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of MK4305 in Patients With Primary Insomnia- Study B
Status: Archived
Clinical Research Facility
mi
from
Detroit, MI
Safety and Efficacy Study in Primary Insomnia Patients-Study B (4305-029)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of MK4305 in Patients With Primary Insomnia- Study B
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Detroit, MI
Safety and Efficacy Study in Primary Insomnia Patients-Study B (4305-029)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of MK4305 in Patients With Primary Insomnia- Study B
Status: Archived
Clinical Research Facility
mi
from
Jackson, MS
Safety and Efficacy Study in Primary Insomnia Patients-Study B (4305-029)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of MK4305 in Patients With Primary Insomnia- Study B
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Jackson, MS
Safety and Efficacy Study in Primary Insomnia Patients-Study B (4305-029)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of MK4305 in Patients With Primary Insomnia- Study B
Status: Archived
Clinical Research Facility
mi
from
New York, NY
Safety and Efficacy Study in Primary Insomnia Patients-Study B (4305-029)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of MK4305 in Patients With Primary Insomnia- Study B
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
New York, NY
Safety and Efficacy Study in Primary Insomnia Patients-Study B (4305-029)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of MK4305 in Patients With Primary Insomnia- Study B
Status: Archived
Clinical Research Facility
mi
from
Asheville, NC
Safety and Efficacy Study in Primary Insomnia Patients-Study B (4305-029)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of MK4305 in Patients With Primary Insomnia- Study B
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Asheville, NC
Safety and Efficacy Study in Primary Insomnia Patients-Study B (4305-029)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of MK4305 in Patients With Primary Insomnia- Study B
Status: Archived
Clinical Research Facility
mi
from
Columbus, OH
Safety and Efficacy Study in Primary Insomnia Patients-Study B (4305-029)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of MK4305 in Patients With Primary Insomnia- Study B
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Columbus, OH
Safety and Efficacy Study in Primary Insomnia Patients-Study B (4305-029)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of MK4305 in Patients With Primary Insomnia- Study B
Status: Archived
Clinical Research Facility
mi
from
Columbia, SC
Safety and Efficacy Study in Primary Insomnia Patients-Study B (4305-029)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of MK4305 in Patients With Primary Insomnia- Study B
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Columbia, SC
Safety and Efficacy Study in Primary Insomnia Patients-Study B (4305-029)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of MK4305 in Patients With Primary Insomnia- Study B
Status: Archived
Clinical Research Facility
mi
from
Dallas, TX
Safety and Efficacy Study in Primary Insomnia Patients-Study B (4305-029)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of MK4305 in Patients With Primary Insomnia- Study B
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Dallas, TX
Safety and Efficacy Study in Primary Insomnia Patients-Study B (4305-029)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of MK4305 in Patients With Primary Insomnia- Study B
Status: Archived
Clinical Research Facility
mi
from
Falls Church, VA
Safety and Efficacy Study in Primary Insomnia Patients-Study B (4305-029)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of MK4305 in Patients With Primary Insomnia- Study B
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Falls Church, VA
Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of ABT-652 in Subjects With Excessive Daytime Sleepiness
A Multiple Dose Study of the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Effect of ABT-652 Administered Once Daily in Subjects With an Excessive Daytime Sleepiness Disorder
Status: Archived
Clinical Research Facility
mi
from
Phoenix, AZ
Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of ABT-652 in Subjects With Excessive Daytime Sleepiness
A Multiple Dose Study of the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Effect of ABT-652 Administered Once Daily in Subjects With an Excessive Daytime Sleepiness Disorder
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Phoenix, AZ
Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of ABT-652 in Subjects With Excessive Daytime Sleepiness
A Multiple Dose Study of the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Effect of ABT-652 Administered Once Daily in Subjects With an Excessive Daytime Sleepiness Disorder
Status: Archived
Clinical Research Facility
mi
from
Glendale, CA
Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of ABT-652 in Subjects With Excessive Daytime Sleepiness
A Multiple Dose Study of the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Effect of ABT-652 Administered Once Daily in Subjects With an Excessive Daytime Sleepiness Disorder
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Glendale, CA
Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of ABT-652 in Subjects With Excessive Daytime Sleepiness
A Multiple Dose Study of the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Effect of ABT-652 Administered Once Daily in Subjects With an Excessive Daytime Sleepiness Disorder
Status: Archived
Clinical Research Facility
mi
from
San Diego, CA
Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of ABT-652 in Subjects With Excessive Daytime Sleepiness
A Multiple Dose Study of the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Effect of ABT-652 Administered Once Daily in Subjects With an Excessive Daytime Sleepiness Disorder
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
San Diego, CA